411 related articles for article (PubMed ID: 28130313)
1. The Genetics of
Gijselinck I; Cruts M; Van Broeckhoven C
Cold Spring Harb Perspect Med; 2018 Apr; 8(4):. PubMed ID: 28130313
[TBL] [Abstract][Full Text] [Related]
2. Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases.
Dedeene L; Van Schoor E; Vandenberghe R; Van Damme P; Poesen K; Thal DR
Acta Neuropathol Commun; 2019 Dec; 7(1):189. PubMed ID: 31791419
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms of Neurodegeneration Related to
Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
[TBL] [Abstract][Full Text] [Related]
4. C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis.
Rohrer JD; Isaacs AM; Mizielinska S; Mead S; Lashley T; Wray S; Sidle K; Fratta P; Orrell RW; Hardy J; Holton J; Revesz T; Rossor MN; Warren JD
Lancet Neurol; 2015 Mar; 14(3):291-301. PubMed ID: 25638642
[TBL] [Abstract][Full Text] [Related]
5. Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders.
Boivin M; Pfister V; Gaucherot A; Ruffenach F; Negroni L; Sellier C; Charlet-Berguerand N
EMBO J; 2020 Feb; 39(4):e100574. PubMed ID: 31930538
[TBL] [Abstract][Full Text] [Related]
6. Disease Mechanisms of
Gendron TF; Petrucelli L
Cold Spring Harb Perspect Med; 2018 Apr; 8(4):. PubMed ID: 28130314
[TBL] [Abstract][Full Text] [Related]
7. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?
van Blitterswijk M; DeJesus-Hernandez M; Rademakers R
Curr Opin Neurol; 2012 Dec; 25(6):689-700. PubMed ID: 23160421
[TBL] [Abstract][Full Text] [Related]
8. Relationship between C9orf72 repeat size and clinical phenotype.
Van Mossevelde S; van der Zee J; Cruts M; Van Broeckhoven C
Curr Opin Genet Dev; 2017 Jun; 44():117-124. PubMed ID: 28319737
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
Wen X; Westergard T; Pasinelli P; Trotti D
Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
[TBL] [Abstract][Full Text] [Related]
10. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
[TBL] [Abstract][Full Text] [Related]
11. Unravelling the clinical spectrum and the role of repeat length in
van der Ende EL; Jackson JL; White A; Seelaar H; van Blitterswijk M; Van Swieten JC
J Neurol Neurosurg Psychiatry; 2021 May; 92(5):502-509. PubMed ID: 33452054
[TBL] [Abstract][Full Text] [Related]
12. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis.
Farg MA; Konopka A; Soo KY; Ito D; Atkin JD
Hum Mol Genet; 2017 Aug; 26(15):2882-2896. PubMed ID: 28481984
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.
Jiang J; Ravits J
Neurotherapeutics; 2019 Oct; 16(4):1115-1132. PubMed ID: 31667754
[TBL] [Abstract][Full Text] [Related]
14. C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.
Xiao S; MacNair L; McLean J; McGoldrick P; McKeever P; Soleimani S; Keith J; Zinman L; Rogaeva E; Robertson J
Brain Res; 2016 Sep; 1647():43-49. PubMed ID: 27134035
[TBL] [Abstract][Full Text] [Related]
15. Insights into C9ORF72-Related ALS/FTD from Drosophila and iPSC Models.
Yuva-Aydemir Y; Almeida S; Gao FB
Trends Neurosci; 2018 Jul; 41(7):457-469. PubMed ID: 29729808
[TBL] [Abstract][Full Text] [Related]
16. The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype.
Cooper-Knock J; Shaw PJ; Kirby J
Acta Neuropathol; 2014 Mar; 127(3):333-45. PubMed ID: 24493408
[TBL] [Abstract][Full Text] [Related]
17. The frequency of the C9orf72 expansion in a Brazilian population.
Cintra VP; Bonadia LC; Andrade HMT; de Albuquerque M; Eusébio MF; de Oliveira DS; Claudino R; Gonçalves MVM; Teixeira AL; de Godoy Rousseff Prado L; de Souza LC; Dourado MET; Oliveira ASB; Tumas V; França MC; Marques W
Neurobiol Aging; 2018 Jun; 66():179.e1-179.e4. PubMed ID: 29449030
[TBL] [Abstract][Full Text] [Related]
18. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
Tomiyama H
Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
[TBL] [Abstract][Full Text] [Related]
19. Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers.
Jackson JL; Finch NA; Baker MC; Kachergus JM; DeJesus-Hernandez M; Pereira K; Christopher E; Prudencio M; Heckman MG; Thompson EA; Dickson DW; Shah J; Oskarsson B; Petrucelli L; Rademakers R; van Blitterswijk M
Mol Neurodegener; 2020 Jan; 15(1):7. PubMed ID: 32000838
[TBL] [Abstract][Full Text] [Related]
20. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
